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Children with epilepsy are usually treated with antiepileptic drugs (AEDS). Some AEDs
adversely affect behavior in susceptible children. Since psychiatric comorbidity is prevalent
in pediatric epilepsy, this paper attempts to disentangle these AED side effects from the
psychopathology associated with this illness. It first outlines the clinical and methodolog-
ical problems involved in determining if AEDs contribute to the behavior and emotional
problems of children with epilepsy. It then presents research evidence for and against the
role AEDs play in the psychopathology of children with epilepsy, and outlines how future
studies might investigate this problem. A brief description of how to clinically separate out
AED effects from the complex illness-related and psychosocial factors that contribute to
the behavior difficulties of children with epilepsy concludes the paper.
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INTRODUCTION
Children with epilepsy, other than benign Rolandic epilepsy (see
debate in Shields and Snead, 2009), are treated with antiepileptic
drugs (AEDs). Parents of newly diagnosed children with epilepsy
frequently complain that their children’s behavior changes after
they start treatment with AEDs. However, psychiatric diagnoses
(Jones et al., 2007) and problem behaviors/emotions (Oostrom
et al., 2000; Austin et al., 2002) are prevalent in children with new
onset epilepsy and in some children even before the first seizure
(Austin et al., 2001). Furthermore, at the same time children with
epilepsy are put on AEDs, they are faced with the challenge of
coping with this illness. This involves experiencing seizures and
dealing with their unpredictability along with the impact of the
disorder on the children’s cognitive, linguistic, academic, social,
and emotional/behavioral functioning; the family’s functioning;
the stigma of the disorder, the response of others to on-going
seizures; and adverse AED behavior and cognitive effects (see
review in Caplan and Bursch, 2012).
From the research perspective, studying the role of AEDs on
the psychiatric comorbidity of children with epilepsy is fraught
with several methodological problems. AEDs are a heterogenous
group of drugs with different underlying mechanisms that can
differentially affect children’s behavior. Some AEDs might trigger
depression, anxiety, and irritability through GABAergic mecha-
nisms (Mula and Sander, 2007). Other AEDs have stimulating
activating effects that might trigger attention deficit hyperactiv-
ity disorder (ADHD), irritability, mania, and psychosis (Mula and
Monaco, 2009). Some AEDs have both depressing and stimulating
effects on behavior.
Due to the varying number and type of drugs and drug com-
binations across children, it is difficult to conduct adequately
powered studies with large enough sample sizes of children on
any one drug or drug combination. In addition, children on AED
polytherapy are more likely to have side effects involving behavior,
particularly irritability, difficulty concentrating, and poor frus-
tration tolerance than children on AED monotherapy (Glauser,
2004). They might also be on higher AED doses than children on
AED monotherapy because they have seizures that are difficult
to control. This is particularly relevant because the likelihood for
behavior and cognitive side effects increases when children are on
higher AED doses (Hussain and Sankar, 2011).
Including children with epilepsy who have low IQ in drug or
behavior studies is an additional potential confounding variable.
The incidence of psychopathology in children with low IQ who
do not have epilepsy is significantly higher than in the general
child population (Rutter et al., 1970; Steffenburg et al., 1996). In
addition to higher rates of psychiatric comorbidity (see review in
Caplan and Austin, 2000), children with epilepsy with low IQ are
more likely to have poor seizure control, be on multiple AEDs, and
experience adverse AED behavior and cognitive effects (Harbord,
2000).
Treatment resistant adult epilepsy is associated with past psy-
chiatric diagnoses and a family history of psychopathology (Hitiris
et al., 2007), variables that also increase the risk for both current
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psychiatric diagnoses and AED induced behavior and cognitive
side effects (Mula and Monaco, 2009). Therefore, to examine AED
effects on behavior and emotions above and beyond effects of
seizure frequency and control, studies should include large sam-
ples of children with epilepsy on AED monotherapy and on AED
polytherapy. They should also collect information on the children’s
IQ, past psychiatric history, prior adverse behavioral responses to
AED treatment, and psychopathology in first-degree relatives.
Antiepileptic drugs also have well-established psychotropic
effects and are first line drugs for the treatment of pediatric
bipolar disorder (see review in Thomas et al., 2011). However,
other than three treatment studies of children with epilepsy on
AED monotherapy (Aldenkamp et al., 1998; Mandelbaum et al.,
2009; Glauser et al., 2010), there have been no prospective studies
that examined if AEDs improve or exacerbate psychiatric symp-
toms in children with epilepsy. Most of the studies conducted
to date in children with epilepsy have examined the association
of seizure variables, including AEDs, with psychiatric diagnoses,
and problem behaviors (see review in Austin and Caplan, 2007).
Even when conducted on large sample sizes of children, these
cross-sectional studies cannot provide information on whether
AEDs cause, exacerbate, or mitigate psychopathology in pediatric
epilepsy.
Determining the optimal control group is an additional
methodological problem in studies on AED effects on behav-
ior and cognition in children with epilepsy. Randomized double
blind controlled studies of AED efficacy and safety typically have
a placebo arm as the control group. In the case of epilepsy, the
placebo arm includes subjects who receive an AED. Thus, drug
add-on or cross-over trials, even in randomized double blind
placebo controlled studies, typically do not have drug free base-
line behavioral data. As a result, behavior differences between the
drug and placebo add-on arms at the end of the trial might reflect
improved behavior due to stopping the current AED, adding the
drug under study, or a combination of both these effects. Mea-
suring subsequent behavior changes following a cross-over back
to the AED or placebo could help address this methodological
problem. However, this additional study phase is not usually con-
ducted. Furthermore, given the developmental changes children
undergo and the wide age of children in AED drug studies, there is
need for a control group of typically developing children without
epilepsy as in Aldenkamp et al. (1998).
Only children with well-controlled seizures can participate in
a prospective AED drug study in which each patient also serves as
his/her own control by comparing the child’s drug naïve behavior
at baseline to the on-drug and off-drug conditions at the end of
the trial. However, children with poorly controlled seizures who
might have a higher risk for adverse behavior effects as described
above, cannot stop taking their AEDs.
Finally, in terms of the quality of data on behavior side effects,
most pediatric AED studies obtain this information by open-
ended general questions to determine if the children experience
any changes in their behavior since the beginning of the study.
They do not use the more reliable and valid baseline and follow-up
structured psychiatric interviews and instruments (e.g., question-
naires) for specific behaviors and emotions. As noted by Hesdorffer
and Kanner (2009), a major limitation of the 11 studies reviewed
by the FDA on AEDs and suicide was the use of spontaneous
reports of adverse event data rather than systematically collected
data based on validated suicide scales.
Aware of the clinical and research challenges involved in teas-
ing out the role of AEDs in the psychopathology of children
with epilepsy, the next section reviews the findings of drug and
behavioral studies that have examined if AEDs are associated with
behavior/emotional problems in children with epilepsy. AED drug
studies examine efficacy and safety of AEDs with adverse behavior
effects included as part of the safety component. As previously
mentioned, most AED drug studies conducted to date have not
used specific instruments to examine the appearance of behavior
problems to AEDs. The cross-sectional and prospective behav-
ioral studies reviewed in this paper have investigated behavior
(using specific instruments) and its association with variables
related to AED treatment such as number and type of AED.
After discussing future research directions to disentangle AED
adverse behavior effects from epilepsy-related psychopathology,
the paper concludes by describing how to clinically evaluate if
AEDs contribute to the behavior/emotional problems in children
with epilepsy.
REVIEW OF RESEARCH
AEDs ARE UNRELATED TO PSYCHOPATHOLOGY
The evidence against a relationship between psychopathology and
AEDs in children with epilepsy comes from community, epidemio-
logical, and drug studies. Community studies identify a subgroup
of children with new onset epilepsy who have psychopathology
before (Austin et al., 2001; Oostrom et al., 2003a) and shortly after
onset of epilepsy (Oostrom et al., 2003a; Jones et al., 2007). Epi-
demiology studies have also shown that having an unprovoked
seizure is a risk factor for psychopathology in children and ado-
lescents (McDermott et al., 1995; Davies et al., 2003; Hesdorffer
et al., 2004, 2006; Russ et al., 2012). Both short-term (Oostrom
et al., 2003b, 2005; Hermann et al., 2008; Austin et al., 2010) and
long-term prospective studies (Wirrell et al., 1997; Camfield and
Camfield, 2009) demonstrate continued psychopathology in chil-
dren with new onset and chronic epilepsy that is unrelated to
seizure variables, including AEDs.
Aldenkamp et al. (1998) found no significant differences in the
self-report of depression, aggression, alertness, attention, memory,
and tiredness in 102 children with well-controlled epilepsy, treated
with AED monotherapy (carbamazepine, valproate, or pheny-
toin), 4 months after a 3-month gradual AED withdrawal com-
pared to 100 healthy control subjects. The parents of the children
with epilepsy, however, noted a significant improvement in the
children’s alertness and activation. These authors concluded that
achieving seizure control rather than AED treatment contributed
to the behavioral and cognitive measures of these children.
A recent child- and parent-proxy quality of life study on 278
children followed 8–9 years after the diagnosis of epilepsy demon-
strated that psychiatric diagnoses were prevalent in 25% of the
sample and that 31% of the children were on AEDs (Baca et al.,
2011). However, unrelated to seizure variables, including AEDs,
child (8/11 scales) and parent-proxy health-related quality of life
(8/12 scales) were significantly associated with the presence of
psychiatric disorders.
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AEDs PLAY A ROLE IN THE PSYCHOPATHOLOGY
Findings of an association between psychopathology and AEDS
in children with epilepsy come mainly from AED drug stud-
ies. Glauser et al. (2010) recently demonstrated that significantly
more children with newly diagnosed absence epilepsy on val-
proate (N = 148) developed problems with attention, based on
the Conners’ Continuous Performance Test, compared to those on
ethosuximide (n= 156) in a 16-week double blind randomized
controlled study.
In contrast to this study, most double blind randomized con-
trolled or add-on studies of AED efficacy and safety collect parents’
reports of adverse events and do not specifically measure problem
behaviors/emotions using reliable and valid instruments. These
and retrospective studies and case series have shown that most
AEDs are associated with cognitive and behavioral adverse effects.
Side effects such as depression, irritability, hyperactivity, increased
anxiety, psychosis, and insomnia have been reported in children
treated with phenobarbital, mysoline, levetiracetam, gabapentin,
felbamate, zonisamide, topiramate, and vigabatrin (see review in
Loring and Meador, 2004). As previously mentioned, children
with low IQ (Harbord, 2000) and learning disability (Depositario-
Cabacar and Zelleke, 2010), increased number of AEDs (Harbord,
2000), high AED doses (Hussain and Sankar, 2011), poor seizure
control (Harbord, 2000; Fastenau et al., 2009), and prior adverse
behavioral or cognitive responses to AEDs are at risk for these
adverse effects. Adult findings suggest that a psychiatric diagnosis
(Mula and Monaco, 2009; Kanner et al., 2012), family history of
psychopathology (Mula and Monaco, 2009), rapidity of titration
(Ettinger et al., 2004; Mula et al., 2009), and presence of an MRI
lesion (Petrovski et al., 2010) also increase the likelihood of adverse
AED behavior effects.
In an open trial, Mandelbaum et al. (2009) examined behav-
ior using child self-report anxiety and depression instruments, IQ,
attention, and memory in 31 children with new onset seizures,
most of whom were on AED monotherapy, before they started
treatment, and then 6 and 12 months later. Other than worsen-
ing of reaction time and increased reaction time variability, the 20
children with focal seizures, mainly treated with carbamazepine,
had improved IQ scores, attention, memory, anxiety, and depres-
sion scores after 1 year. There was no significant improvement
in these measures in the 11 children with primary generalized
seizures, of whom 10 had absence seizures, and were treated with
ethosuximide. However, the lower baseline IQ score of this sub-
group and the higher rate of poor seizure control at the 12-month
follow-up might account for the lack of behavioral improvement
in the absence group. These authors, nevertheless, concluded that
there are few AED behavioral and cognitive adverse effects over a
12-month period.
Regarding behavioral studies, a 36-month follow-up study of
300 children with new onset seizures demonstrated continued
improved behavior that was not predicted by seizure variables,
including AEDs (Austin et al., 2011). Yet, the children with con-
tinued problem behaviors had poor seizure control, worsening
of their verbal skills and processing speed, poor self-esteem, and
depression (Austin et al., 2010). Additional studies are needed to
determine the role played by AED treatment in these findings for
the following reasons. Level of seizure control is related to AED
treatment (number of AEDs and dose) and both these variables
play a role in the cognitive, linguistic, and academic achievement
difficulties of children with epilepsy with average intelligence (see
review in Hamiwka et al., 2011). But impaired verbal processing
skills and speed have a negative effect on literacy and academic
performance, variables related to poor self-esteem and mood in
children without epilepsy (Schuele, 2004; Corapci et al., 2006; Voci
et al., 2006; van Daal et al., 2007). Thus, AEDs might indirectly
impact behavior through their effect on cognition and language.
Animal studies of AED effects on behavior and cognition
Three recent animal studies demonstrate that neonatal adminis-
tration of AEDs to rat pups who do not have seizures can cause
neuronal death and abnormal functioning and maturation in sur-
viving neurons together with short-term and long-term effects
on behavior and cognition (Forcelli et al., 2011, 2012a,b). Thus,
neonatal administration for a week of phenobarbital, phenytoin,
and lamotrigine impacted adult rodent behavior involving spa-
tial learning and memory, emotional memory, anxiety, drive, and
social behavior suggest that AEDs might impact brain devel-
opment and related psychiatric and cognitive comorbidities in
pediatric epilepsy (Forcelli et al., 2012a). Rat pups treated with
phenobarbital and phenytoin demonstrated cell death in the lim-
bic system (Forcelli et al., 2011). Single phenobarbital, phenytoin,
and lamotrigine injections in the neonatal period were associated
with a lack of normal increased excitatory and inhibitory activity,
delayed striatal synaptic maturation in the striatum, and impaired
striatal dependent reversal learning in rat pups (Forcelli et al.,
2012b).
An additional animal study identified schizophrenia-like
behaviors in adult rats treated with a single dose of phenobarbital
during the neonatal period (Bhardwaj et al., 2012). This finding
is particularly interesting in light of increased incidence of schiz-
ophrenia in individuals who experienced febrile seizures during
childhood both with and without the subsequent development of
epilepsy (Vestergaard et al., 2005). Although phenobarbital was
used to treat febrile seizures, this study provided no information
on current AED treatment and whether the subjects with schizo-
phrenia were treated with phenobarbital for their febrile seizures
compared to those without this illness.
An early large prospective study in 8–36 month old children
with febrile seizures found a decrease in IQ of 7.03 points in
children treated with phenobarbital for 2 years that was partially
reversible (a 5.2 point decrease in IQ) 6 months after stopping this
AED (Farwell and Batzel, 1985). Other researchers, however, found
reversible adverse effects including hyperactivity, sleep difficulties,
fussy behavior, impaired attention, and memory, but no decrease
in IQ in children with febrile seizures treated with phenobarbital
(see review in Lux, 2010).
SUMMARY AND FUTURE RESEARCH DIRECTIONS
Weighing the available evidence from the clinical studies, the
prevalence of psychopathology in children with epilepsy with aver-
age intelligence does not appear to reflect AED effects. Despite
similar high rates and types of psychopathology in children with
epilepsy who have normal intelligence and different epilepsy
syndromes (e.g., localization-related epilepsy, benign Rolandic
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epilepsy, childhood absence disorder, and juvenile myoclonic
epilepsy; Hamiwka et al., 2011), these syndromes differ in the
cognitive, linguistic, and seizure correlates (including AEDs) of
psychopathology (Caplan et al., 2004, 2008). This underscores the
need for large prospective AED treatment studies to determine the
effect on psychopathology in children with these syndromes.
But AED treatment in children with epilepsy is associated
with cognitive, linguistic, and academic difficulties (see review in
Caplan, 2010), variables that increase the risk for psychopathol-
ogy in the general population (Beitchman et al., 2001; Wilson et al.,
2009; Chavira et al., 2010). Thus, AEDs might be indirectly associ-
ated with the psychopathology of children with epilepsy through
their effect on subtle to mild cognitive and linguistic deficits. The
recent findings of short-term and long-term effects of neonatally
administered AEDs on behavior, cognition, and brain develop-
ment in rat pups and adults without seizures (Forcelli et al., 2011,
2012a,b) support this conclusion. They also support the need
for prospective studies to examine effects of AEDs on the on-
going development of the brain during childhood and adolescence
(Shaw et al., 2010) and their role in the psychiatric and cognitive
comorbidities of pediatric epilepsy.
The complex nature of the association among psychopathology,
cognition, and language and the difficulty disentangling effects of
AEDs from these comorbidities is even more pronounced in chil-
dren with low IQ for several reasons (see review in Caplan and
Austin, 2000). Intellectual disability and impaired language are
associated with early onset of epilepsy, difficult to control seizures,
and AED polytherapy. Low IQ and language impairment increase
the risk for psychopathology and behavior disturbances in children
with both intellectual disability and epilepsy. Impaired cognitive
and verbal skills make it more difficult to establish a valid psy-
chiatric diagnosis in low IQ children. Therefore, future studies
on AEDs and psychopathology need to separate between children
with average and low IQ and use behavior instruments that are
reliable and valid for children with average intelligence and for
those with intellectual disability.
THE CLINICAL PERSPECTIVE
Adult epilepsy patients with depression, anxiety disorders, and
sub-syndromic depression have significantly higher AED adverse
effect profiles than those without these diagnoses (Kanner et al.,
2012). However, children aged 10 and under do not have the abil-
ity to self-monitor and verbalize AED effects on their behavior,
emotions, and functioning. They act them out. For example, AED
induced tiredness and sedation can cause poor frustration toler-
ance as well as hyperactive, irritable, agitated, angry, and aggressive
behavior in some children but moodiness, irritability, crying, and
withdrawal in others.
Parents often interpret these behaviors as “bad” or “attention
seeking” and are unaware of a possible connection with AED
induced sedation. When they consult the child’s physician on the
child’s behavior problem, the child might be mistakenly diagnosed
as having ADHD or bipolar disorder if the child acts out or
depressed if the child is withdrawn and moody.
Alternatively, a child who is experiencing learning difficulties
due to AED induced problems with attention, prolonged reaction
time, sedation, and word finding difficulties might either act out
or respond with internalizing depressed and withdrawn behavior
as described above. The child might also be labeled as “bad” or
“attention seeking” or get one of the above mentioned psychiatric
diagnoses. Psychotropic treatment for these psychiatric diagnoses
does not address the AED induced learning disorder and the child’s
behavior might get worse due to added sedation and slowing of
cognitive functions.
Therefore, possible AED adverse behavioral effects should be
considered in the differential diagnosis of behavior or emotional
problems in each child with epilepsy. This should include obtain-
ing a detailed time line from the parents on the chronology of the
development and presentation of the child’s behavior problems.
Changes in behavior that occur after starting an AED, increasing a
dose, or adding on an AED might reflect side effects. However, in
both children with new onset and chronic epilepsy, these behav-
ioral changes might also represent difficulties the child is having
dealing with the illness and/or subclinical on-going seizures that
impair the child’s cognition and behavior (see review in Caplan
and Bursch, 2012).
To prevent misdiagnosis and mismanagement, these children
should undergo a comprehensive psychiatric assessment to deter-
mine if the behavioral/emotional symptoms reflect the psychiatric
comorbidity of pediatric epilepsy, AED adverse effects; the cog-
nitive, linguistic, and academic achievement/learning problems
prevalent in these children, or psychosocial factors such as the
child’s response to having epilepsy, how parents cope with the ill-
ness and its comorbidities, and the impact of all these factors on
parenting and family functioning. This involves obtaining detailed
information from the parents and the child separately and use of
clinical techniques described in (Caplan and Bursch, 2012).
In conclusion, the need to conduct a comprehensive psychiatric
assessment to tease out the previously described causes of behav-
ior and emotional disturbances in children with epilepsy has both
clinical and research implications. From the clinical perspective,
it is essential for adequate treatment of the causes of the child’s
symptoms. From the research perspective, structured psychiatric
interviews and established instruments of behavior and emotions
used in studies of children with epilepsy yield psychiatric diagnoses
and identify symptoms. They do not identify the complex factors
that trigger and/or exacerbate these disorders and their symp-
toms, including AED adverse effects. Reliable and valid clinically
comprehensive psychiatric evaluations in well designed prospec-
tive studies could help determine the role played by AEDS in the
psychopathology of children with epilepsy and identify children
at risk for adverse treatment effects on behavior.
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